Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

The treatment of patients with infected implantable cardioverter-defibrillator systems.

O'Nunain S, Perez I, Roelke M, Osswald S, McGovern BA, Brooks DR, Torchiana DF, Vlahakes GJ, Ruskin J, Garan H.

J Thorac Cardiovasc Surg. 1997 Jan;113(1):121-9.

2.

Implantable cardioverter-defibrillator endocarditis secondary to Candida albicans.

Brown LA, Baddley JW, Sanchez JE, Bachmann LH.

Am J Med Sci. 2001 Sep;322(3):160-2. Review.

PMID:
11570782
3.

Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.

Rivera NT, Bray N, Wang H, Zelnick K, Osman A, Vicuña R.

Ther Adv Cardiovasc Dis. 2014 Oct;8(5):193-201. doi: 10.1177/1753944714539406. Epub 2014 Jun 20. Review.

PMID:
24951637
4.

Implantable cardioverter-defibrillator: present and future indications.

Block M, Scheld H, Breithardt G.

Arch Mal Coeur Vaiss. 1996 Feb;89 Spec No 1:141-7. Review.

PMID:
8734176
5.

[Infectious complications of cardioverter/defibrillators--case report and review of the literature].

Hollenstein U, Thalhammer F, Burgmann H, Breyer S.

Acta Med Austriaca. 1996;23(5):164-7. Review. German.

PMID:
9082746
6.

Interactions between antiarrhythmic drugs and implantable cardioverter-defibrillators.

Dougherty AH.

Curr Opin Cardiol. 1996 Jan;11(1):2-8. Review.

PMID:
8664528
7.

Infections of implantable cardioverter defibrillators: approach to management.

Spratt KA, Blumberg EA, Wood CA, Kutalek SP, Reboli AC.

Clin Infect Dis. 1993 Oct;17(4):679-85. Review.

PMID:
8268349
8.

Permanent explantation of implantable cardioverter defibrillators.

Geist M, Newman D, Greene M, Paquette M, Dorian P.

Pacing Clin Electrophysiol. 2000 Dec;23(12):2024-9. Review.

PMID:
11202242
9.

Implantable cardioverter-defibrillators: implications for the nonelectrophysiologist.

Pinski SL, Trohman RG.

Ann Intern Med. 1995 May 15;122(10):770-7. Review.

PMID:
7717600
10.

Implantable cardioverter-defibrillator advances.

Lerman RD, Cannom DS.

Curr Opin Cardiol. 1996 Jan;11(1):16-22. Review.

PMID:
8664527
11.

[Fatal surgical extraction of cardiac resynchronisation therapy defibrillator leads in a context of endocarditis due to methicillin-resistant Staphylococcus epidermidis. A case report and review of literature].

Verdier-Watts F, Zouaghi O, Berend M, Wey PF, Farhat F, Bonnefoy E, Mioulet D, Griffet V.

Ann Cardiol Angeiol (Paris). 2015 Feb;64(1):43-5. doi: 10.1016/j.ancard.2014.04.013. Epub 2014 Apr 26. Review. French.

PMID:
24836938
12.

Patients' perception of implantable cardioverter defibrillator deactivation at the end of life.

Hill L, McIlfatrick S, Taylor B, Dixon L, Harbinson M, Fitzsimons D.

Palliat Med. 2015 Apr;29(4):310-23. doi: 10.1177/0269216314550374. Epub 2014 Sep 19. Review.

PMID:
25239128
13.

Cardiovascular implantable electronic device infections: associated risk factors and prevention.

Rohacek M, Baddour LM.

Swiss Med Wkly. 2015 Jul 31;145:w14157. doi: 10.4414/smw.2015.14157. eCollection 2015. Review.

14.

Clinical use of antibacterial mesh envelopes in cardiovascular electronic device implantations.

Hirsh DS, Bloom HL.

Med Devices (Auckl). 2015 Jan 12;8:71-8. doi: 10.2147/MDER.S58278. eCollection 2015. Review.

Supplemental Content

Support Center